THE THROMBOSIS RESEARCH INSTITUTE

Registered charity 800365 · accounts filings on the Charity Commission register

Research has continue to focus on three broad ares: venous thromboembolic disease, atherothrombosis and cancer associated thrombosis. Educational symposia bring together researchers and practising clinicians to disseminate the results of research.

Causes: The Advancement Of Health Or Saving Of Lives · website · Get email alerts

Latest income
£3.4m
Latest spending
£3.2m
Registered
1988
Accounts read
FY2025

Financial health, per its FY2025 accounts

The accounts state that the charity reported a surplus of £228,748 for the year ended 31 July 2025, with total unrestricted reserves of £7,409,920. The Trustees consider the financial health of the Institute to be good, noting that unrestricted annual expenditure was £3.22m and that the charity continues to attract funds to support its research and educational activities.

Automated summary of the FY2025 accounts; the evidenced findings below carry the verbatim passages.

What the accounts disclose

Highest-paid employee band: £200,001 - £210,000 — above the 90th percentile for charities its size (median £70k)
“In the band £200,000 - £210,000 1” — page 31
Per its FY2025 accounts as filed with the Charity Commission.
Largest income source: Charitable activities (70% of income)
“Income from charitable activities - Research 2,382,840” — page 27
Per its FY2025 accounts as filed with the Charity Commission.
Reserves policy: not less than one year’s running expenses (held: £7.4m)
“The Institute is engaged in carrying out scientific research which requires it to maintain a ‘state of the art’ research facility and for which the Trustees consider it prudent to maintain reserves where possible of not less than one year’s running expenses.” — page 10
Per its FY2025 accounts as filed with the Charity Commission.
Related-party transaction: The Institute is connected with the Thrombosis Research Trust (a charitable trust that is a registered charity number 275275) as it has the object of promoting and funding research into the prevention and treatment of thrombosis disease, which it fulfils by supporting the Institute. At the year-end, Mr Patrick Burgess was a Trustee of the Institute and the Thrombosis Research Trust.
“The Institute is connected with the Thrombosis Research Trust (a charitable trust that is a registered charity number 275275) as it has the object of promoting and funding research into the prevention and treatment of thrombosis disease, which it fulfils by supporting the Institute. At the year-end, Mr Patrick Burgess was a Trustee of the Institute and the Thrombosis Research Trust.” — page 5
Per its FY2025 accounts as filed with the Charity Commission.
Trading subsidiary: TRI Technology Transfer Limited, TRI Clinical Trials Limited
“The investments in group undertakings consist of shares and loans in the institute’s subsidiary undertakings as follows: TRI Technology Transfer Limited (intellectual property) TRI Clinical Trials Limited (Research and intellectual property)” — page 33
Per its FY2025 accounts as filed with the Charity Commission.

Accounts audited by HaysMac LLP. Discloses 5 of 6 completeness components.

Year-over-year changes

Comparing this charity’s FY2024 and FY2025 accounts as analysed by this site.

Property (HM Land Registry)

1 registered title in England and Wales held by the charity’s company or corporate body (1 freehold). All charity-held property. Contains HM Land Registry data © Crown copyright, OGL v3.0.

Structured financials (annual return, FY ending 31/07/2025)

Total income
£3.4m
Total spending
£3.2m
Reserves (reported)
£10.1m
Employees
17

Reported reserves equal ~37.5 months of spending — in the top quarter for charities its size (median 4.8 months; benchmarks).

Per its annual return, largest income source: Charitable activities (70% of income) — components as reported reconcile to the return’s total income; not from the accounts narrative.

Per its annual return, cost of raising funds: 0.0% of total income — below the median for charities its size (5.2%) (benchmarks).

Trustees · trustee networks

Trustee list from the Charity Commission register (current, not historical).

Operates in: Throughout England And Wales

Income and spending

Financial year endIncomeSpending
31/07/2025£3.4m£3.2m
31/07/2024£3.1m£2.9m
31/07/2023£1.7m£3.2m
31/07/2022£3.5m£4.4m
31/07/2021£3.3m£6.9m

Common questions

Is THE THROMBOSIS RESEARCH INSTITUTE financially healthy?

Per its FY2025 accounts: The accounts state that the charity reported a surplus of £228,748 for the year ended 31 July 2025, with total unrestricted reserves of £7,409,920. The Trustees consider the financial health of the Institute to be good, noting that unrestricted annual expenditure was £3.22m and that the charity continues to attract funds to support its research and educational activities. Its FY2025 accounts were audited by HaysMac LLP.

What does the highest-paid employee of THE THROMBOSIS RESEARCH INSTITUTE earn?

Per its FY2025 accounts, the highest-paid employee was in the £200,001 - £210,000 band.

Funders of similar charities

Funders whose accounts show grants to charities similar to this one (and no recorded grant to this charity) — a starting list for fundraisers.

FunderSimilar charities fundedAmount to them
THE JOHN HEMINGWAY CHARITABLE TRUST1£10k
MATTHEW GOOD FOUNDATION1£2k
THE KNOLL CHARITABLE TRUST1£250

Charities like this

Semantically similar by activities and financial character, from our analysed corpus. Compare with THROMBOSIS UK.

Side by side with its peers

CharityIncomeTop pay bandStaff >£60kReserves vs policyFundraising costGoing concern
THE THROMBOSIS RESEARCH INSTITUTE£3.4m£200,001 - £210,000—above—no doubt
THROMBOSIS UK FY2025£293k—0unclear—no doubt
THE CANCER TREATMENT AND RESEARCH TRUST CIO FY2024£502k—0above—no doubt
PSYCHIATRY RESEARCH TRUST FY2025£388k—0unclear—no doubt
PTEN RESEARCH FOUNDATION FY2025£716k£180,001 - £190,000—unclear—no doubt
THE GEORGE INSTITUTE FOR GLOBAL HEALTH (UK) FY2025£2.9m——unclear—no doubt

Each row is that charity’s latest analysed filing; every value is quote-backed on its own page.